1 / 28

Blood groups and Hemostasis

Blood groups and Hemostasis. Dpt. Of Normal, Pathological and Clinical Physiology. Blood groups. blood transfusion often resulted in agglutination and hemolysis , often led to death (renal shock)

britney
Download Presentation

Blood groups and Hemostasis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Blood groups and Hemostasis Dpt. Of Normal, Pathological and Clinical Physiology

  2. Blood groups • blood transfusion often resulted in agglutination and hemolysis, often led to death (renal shock) • antibodies in the plasma of one blood react with antigens on the surface of the red cells of another blood • more than 30 commonly occurring antigens • hundreds of rare antigens • two particular groups of antigens: AB0 and Rh systems are immunogenic enough to cause hemagglutination

  3. Landsteiner Jánský actual nomenclature A II A B III B C I 0 --- IV AB AB0 system - history

  4. AB0 system • four groups: A, B, AB, 0 • two (3) agglutinogens = antigens on the surface of RBC • two agglutinins = antibodies present in the plasma • agglutinogens = glycoprotein, oligosaccharides having different carbohydrate at their endings A – N-acetylgalactosamin B – galactose H – fucosotransferasa

  5. AB0 agglutinogens • determined by two genes, one on each of two paired chromosomes • 0 is functionless gene; O = “ohne” • A gene determines A group; B gene determines B group • codominancy: • blood type A: genotype AA, A0 • blood type B: genotype BB, B0 • blood type AB: genotype AB • blood type 0: genotype 00 (or hh “Bombay” + either AA, AO, BB, BO, or AB) + Hh or HH

  6. AB0 agglutinogens • antigen H forms the antigen-carrying molecule • subtypes of A antigen A1…A6, different immunogenity • detectable in 4weeks old embryo • during labor, 20-30% of the immunogenity in adult (> 18 years)

  7. AB0 agglutinins • antibodies present in the plasma • γ-globulins, IgGand IgM molecules (pentamers, not diffusing trough the placenta) • not present immediately after birth • produced in 2-8 months after birth by plasma cells (specialized B-cells, stimulated by similar oligosaccharides often expressed in the nature – food, intestinal bacterias) • highest titer around at 10 years of age • antibodies against the AB0type not present in the blood • group A  antibodies anti-B • group B  antibodies anti-A • group AB  no antibodies • group 0  antibodies anti-A and anti-B

  8. Frequencies of the different blood types • differ according to geographic and time locations • group A: Atlantic population and Eskimos (60%) • group B: east-south Asia, India (40%) • group 0: America'sIndians (100%) • the Czech Rep.: A-42 %, 0-32 %, B-18 %, AB-8 % • white people: A-47 %, 0-41 %, B-9 %, AB-3 % • universal donor, universal acceptor - antigens • autotransfusion

  9. Rh system II • Landsteiner 1940 • C, D, E antigens (D is most immunogenic) • 85 % white people Rh+, 99 % Asians Rh+, African black 100 % Rh+ • clinical importance: • blood transfusion • pregnancy: mother Rh negative and fetus Rh positive, antibodies diffuse trough the placenta (erythroblastosis fetalis, new-born hemolysis, kernicterus, jaundice) in both cases the exposition to the antigen is needed first (sensitization), because anti-Rh antibodies are NOT normally produced – Rh antigen is not often present in the nature

  10. Other systems • MNSs: very low immunogens, normally no natural antibodies in blood occur, Landsteiner 1927 • P system: Landsteiner, low immunogens ( 80% people); subtypes • Kell, Duffy, Kidd, Lutheran, Diego

  11. Hemostasis • three mechanisms: • vascular spasm • formation of a platelet plug • blood coagulation

  12. Vasoconstriction • neural: nervous reflexes induces by activation of pain fibers, local myogenic spasm • humoral: thromboxan A2andserotoninand other substances produced by activated platelets • vasoconstriction itself stops the bleeding in vessels as large as a. radialis (under ideal circumstances / i.e. crushed, not cut) • lasts for minutes or even hours

  13. Platelets • do not have nuclei, oval discs 2-4 mm, half-life 4-8days • megakaryocytes (1000-5000 platelets) • 150 – 300.000 per 1 microliter • platelets cytoplasm contains: • actin and myosin and thrombosthenin (platelet contraction) • vesicles containing Ca2+ , serotonin, ADP • enzymes that synthesize prostaglandins • a-granules: PDGF, coagulating factors, von Willebrandt factor (adhesion) • lysozomy • platelets membrane contains large amount of phospholipids

  14. platelets function • adhesion, collagen: vonWillebrandt Factor released from endothel • activation: swelling, irregular forms, pseudopods, release of serotonin, vWF, tromboxan A2, ADP  activation of other platletes • aggregation: stimulated by trombin, tromboxan A2, vWF, fibrinogen  platelet plug (loose, then fibrin threads form an unyielding plug) closing the minute ruptures (small vessels, many times per day, petechiae)

  15. Thrombopoetin • produced bythe liver,little in kidney • receptors in plasma membrane of stem cells and megakaryocytes andplatelets (regulation) • constant production, regulation by the number of platelets / the more platelets  the more T bound to them  less T act on stem cells and megakaryocytes • liver diseases  bleeding (together with lower production of clotting factors)

  16. clotting pathways • the sense is to form fibrinmonomers and then polymers = fibrin fibers (threads) within few seconds (and pesence of Ca2+) • fibrin is formed by activated thrombin  all activators of prothrombin are called trombokinases (tissue and plasmatic trk) intrinsicpathway extrinsic pathway common

  17. clotting factors - proenzymes * vitamin K dependent

  18. clotting pathway – common X Þ Xa: activated either by intrisic or extrinsic pathway II Þ IIa: protrombin, trombin XIII Þ XIIIa I Þ Ia:fibrinogenfibrin +V stabilization

  19. clotting pathway – intrinsicsubmucosis, phospholipids released from platelets XII Þ XIIa: catalyzed by kalikrein a kininogen, activated by negative charges (glass, collagen) XI Þ XIa: activated by XIIa IX Þ IXa: activated byXIa X Þ Xa 1 – 6 minutes +VIII

  20. clotting pathway – extrinsictissue, lipoproteins VII Þ VIIa: activated by tissue factor III(thromboplastin) which is released from damaged tissues X Þ Xa: activated byVIIa 10 seconds, explosive (VIIaactivatesIXof intrinsic pathway as well)

  21. anticlotting mechanisms • endothelial smoothness, glycocalyx (mucopolysaccharide repelling the factors) and thrombomodulin (protein binding thrombin) • fibrin itself remove thrombin from the blood • catching of activated factors by liver • consumption of activated factors • antithrombin III: proteases inhibitor, its binding is facilitated by heparin  no activation of IX, X, XI, XII • heparin – polysaccharide released from mast cells and basophils

  22. fibrinolysis • thrombomodulin (endotelial wall) catalyzesactivation of protein C by thrombin • activated protein C (APC) • inactivates VIII • inactivates V • activates tissue plasminogen activator (TPA) • TPA catalyzesactivation of plasminogen to form plasmin, plasmin causes lysis of the clot • alteplase (recombinant), streptokinase, urokinase

  23. anticoagulants • heparin (+ antithrombin III) • citrate, oxalate (bind Ca2+) • coumarin, warfarin (inhibition of vitamin K)

  24. excessive bleeding • failure of blood clotting (coagulopathy) • hematoms, joint bleeding • platelets failure thrombocytopathy • petechiae • vessels defects • petechiae

  25. innate coagulopathy • abnormality or deficiency of one of the clotting factors • hemophilia A, classic h. • defect of VIII (3 subunits, defect of the clotting factor) • transmitted genetically, X chromosome, males • hemophilic arthropathy, muscle bleeding in legs • 1 z 10000 born males • von Willebrandt disease: defect of VIII, all subunits impaired (vW factor, antigen factor and clotting factor) • hemophilia B: defect of IX • other disorders when impaired factors I, II, V, VII, X, XIII • deficiency of XI almost without any clinical signs

  26. acquired coagulopthies • liver diseases (cirrhosis) – deficiency of all factors • heparin • deficiency of vitamin K • DIC • sepsis, leukemia, AB0 incompatibility

  27. defects of platelets • trombocytopenia: aplasia (radiation), hypovitaminosis B12, sequestration • trombocytopathy: acetylsalicylic acid (inhibition of COX Þ suppresses synthesis of thromboxan A2 and secretion of ADP

  28. Defekty cév • von Willebrandtova choroba: defekt endotelu, chybí vWF Þ porucha adheze, nedostatek VIII (vWF je jeho přenašeč) • skorbut • vrozené defekty pojiva: Rendu-Osler, Henoch-Schönlein

More Related